Related Experiment Videos
Localization of d- and l-methadone after intraventricular injection into rat brains
The Journal of Pharmacology and Experimental Therapeutics
|October 1, 1970
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Posttranslational modification of nerve proteins by amino acids.
Restorative neurology and neuroscience·2011
Post-translational modification of proteins by arginine and lysine following crush injury and during regeneration of rat sciatic nerves.
Restorative neurology and neuroscience·2011
AN INACTIVE PRECURSOR OF STREPTOCOCCAL PROTEINASE.
The Journal of experimental medicine·2009
THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI.
The Journal of experimental medicine·2009
Mitochondrial proteomic signatures of postcardiac arrest brain injury reveal potential therapeutic targets.
The Journal of pharmacology and experimental therapeutics·2026
BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278.
The Journal of pharmacology and experimental therapeutics·2026
Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-α suppression.
The Journal of pharmacology and experimental therapeutics·2026
Modafinil ameliorates sleep deprivation-induced memory impairment under acute hypobaric hypoxia via biphasic Cyp3a11 regulation and altered pharmacokinetics.
The Journal of pharmacology and experimental therapeutics·2026
Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.
The Journal of pharmacology and experimental therapeutics·2026
Repurposing ribavirin for oncology: Integrating metabolism, signaling, and translational control.
The Journal of pharmacology and experimental therapeutics·2026